Peptide-conformed β2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase

Human Immunology

Volumn 60, Issue 12, 1999, Pages 1216-1226

  Demaria, Sandra ^a   Devito Haynes, Lynn D ^b   Salter, Russell D ^c   Burlingham, William J ^b   Bushkin, Yuri ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Metalloproteinase; Soluble HLA; Transplantation

Indexed keywords

BETA 2 MICROGLOBULIN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ENZYME; METALLOPROTEINASE; IMMUNOGLOBULIN HEAVY CHAIN; PEPTIDE;

ALLOGRAFT; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DISSOCIATION; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; CELL LINE; CELL MEMBRANE; GENETICS; IMMUNOLOGY; METABOLISM; MUTAGENESIS; SOLUBILITY; SOLUTION AND SOLUBILITY;

BETA 2-MICROGLOBULIN; CELL LINE, TRANSFORMED; CELL MEMBRANE; HLA-A2 ANTIGEN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; METALLOENDOPEPTIDASES; MUTAGENESIS; PEPTIDES; SOLUBILITY; SOLUTIONS;

EID: 0033233465     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00113-5     Document Type: Article

References (49)

1. Jardetzky T.S., Lane W.S., Robinson R.A., Madden D.R., Wiley D.C. Identification of self peptides bound to purified HLA-B27. Nature. 353:1991;326.
2. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.-G. Allele-specific motifs revelead by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290.
3. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329:1987;506.
4. Elliott T. How do peptides associate with MHC class I molecules? Immunol Today. 12:1991;386.
5. Bijlmakers M.J., Ploegh H.L. Putting together an MHC class I molecule. Curr Opin Immunol. 5:1993;21.
6. Bresnahan P.A., Barber L.D., Brodsky F.M. Localization of class I histocompatibility molecule assembly by subfractionation of the early secretory pathway. Hum Immunol. 53:1997;129.
7. Fellous M., Kamoun M., Wiels J., Dausset J., Clements G., Zeuthen J., Klein G. Induction of HLA expression in Daudi cells after cell fusion. Immunogenetics. 5:1977;423.
8. Owen M.J., Kissonerghis A.-M., Lodish H.F. Biosynthesis of HLA-A and HLA-B antigens in vivo. J Biol Chem. 255:1980;9678.
9. Spies T., Cerundolo V., Colonna M., Cresswell P., Townsend A., DeMars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. J Immunol. 355:1992;644.
10. Neefjes J.J., Momburg F., Hammerling G. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 261:1993;769.
11. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761.
12. Ljunggren H.-G., Stam N.J., Ohlen C., Neefjes J.J., Hoglund P., Heemels M.-T., Bastin J., Schumacher T.N.M., Townsend A., Karre K., Ploegh H.L. Empty MHC class I molecules come out in the cold. Nature. 346:1990;476.
13. Townsend A., Elliott T., Cerundolo V., Foster L., Barber B., Tse A. Assembly of MHC class I molecules analyzed in vitro. Cell. 62:1990;285.
14. Monaco J.J. A molecular model of MHC class-I-restricted antigen processing. Immunol Today. 13:1992;173.
15. Stam N.J., Spits H., Ploegh H.L. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol. 137:1986;2299.
16. Stam N.J., Vroom T.M., Peters P.J., Pastoors E.B., Ploegh H.L. HLA-A and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol. 2:1990;113.
17. Schnabl E., Stockinger H., Majdic O., Gaugitsch H., Lindley I.J.D., Maurer D., Hajek-Rosenmayr A., Knapp W. Activated human T lymphocytes express MHC class I heavy chains not associated with β2-microglobulin. J Exp Med. 171:1990;1431.
18. Grassi F., Meneveri R., Gullberg M., Lopalco L., Rossi G.B., Lanza P., De Santis C., Brattsand G., Butto S., Ginelli E., Beretta A., Siccardi A.G. Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J Exp Med. 174:1991;53.
19. Demaria S., Schwab R., Bushkin Y. The origin and fate of β2m-free MHC class I molecules induced on activated T cells. Cell Immunol. 142:1992;103.
20. Madrigal J.A., Belich M.P., Benjamin R.J., Little A.-M., Hildebrand W.H., Mann D.L., Parham P. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. J Exp Med. 174:1991;1085.
21. Demaria S., Bushkin Y. CD8 and β2-microglobulin-free MHC class I molecules in T cell immunoregulation. Int J Clin Lab Res. 23:1993;61.
22. Demaria S., Schwab R., Gottesman S.R.S., Bushkin Y. Soluble β2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem. 269:1994;6689.
23. Carreno B.M., Hansen T.H. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface. Eur J Immunol. 24:1994;1285.
24. Levitsky V., Zhang Q.-J., Levitskaya J., Masucci M.G. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J Exp Med. 183:1996;915.
25. Bix M., Raulet D. Functionally conformed free class I heavy chains exist on the surface of β2-microglobulin negative cells. J Exp Med. 176:1992;829-834.
26. DeVito-Haynes L.D., Jankowska-Gan E., Heisy D., Jutte N.H.P.M., Balk A.H.M.M., Weimar W., Claas F.H.J., Warner T.F.C., Mentzer R.M., Love R.B., Burlingham W.J. Donor-derived HLA class I proteins in the serum of heart transplant recipients. J Heart Lung Transplant. 15:1996;1012.
27. DeVito-Haynes L.D., Jankowska-Gan E., Heisy D., Meyer K.C., Love R.B., Burlingham W.J. Soluble HLA class I in epithelial lining fluid of lung transplants. Associations with graft outcome. Hum Immunol. 52:1997;95.
28. DeVito-Haynes L.D., Demaria S., Bushkin Y., Burlingham W.J. The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro proposed mechanism for soluble HLA release in transplant rejection . Hum Immunol. 59:1998;426.
29. Zhai Y., Knechtle S. Two distinct forms of soluble MHC class I molecules synthesized by different mechanisms in normal rat cells in vitro. Hum Immunol. 59:1998;415.
30. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 329:1987;512.
31. Gearing A.J.H., Beckett P., Christodoulou M., Churchill M., Clements J., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., Gordon J.L., Leber T.M., Mangan M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G., Wood L.M., Wooley K. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature. 370:1994;555.
32. Salter R.D. Mutant HLA-A201 heavy chains with lowered affinity for β2m are transported after growth at reduced temperatures. Hum Immunol. 35:1992;40.
33. Utz U., Koenig S., Coligan J.E., Biddison W.E. Presentation of three different viral peptides, HTLV-1 tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2 1 molecule . J Immunol. 149:1992;214.
34. Safrit J.T., Lee A.Y., Andrews C.A., Koup R.A. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients. J Immunol. 153:1994;3822.
35. Storkus W.J., Zeh H.J., Salter R.D., Lotze M.T. Identification of T-cell epitopes rapid isolation of class I-presented peptides from viable cells by mild acid elution . J Immunother. 14:1993;94.
36. 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound. J Immunol. 149:1992;1896.
37. Allen R.A., O'Callaghan C.A., McMichael A.J., Bowness P. Cutting edge HLA-B27 can form a novel β2-microglobulin-free heavy chain homodimer structure . J Immunol. 162:1999;5045.
38. Matko J., Bushkin Y., Wei T., Edidin M. Clustering of class I HLA molecules on the surface of activated and transformed human cells. J Immunol. 152:1994;3353.
39. Due C., Simonsen M., Olsson L. The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor implications for the range of biological functions of histocompatibility antigens . Proc Natl Acad Sci USA. 83:1986;6007.
40. Bushkin Y., Demaria S., Le J., Schwab R. Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes. Proc Natl Acad Sci USA. 85:1988;3985.
41. Bene L., Balazs M., Matko J., Most J., Dierich M.P., Szollosi J., Damjanovich S. Lateral organization of the ICAM-1 molecule at the surface of human lymphoblasts a possible model for its co-distribution with the IL-2 receptor, class I and class II HLA molecules . Eur J Immunol. 24:1994;2115.
42. Lagaudriere-Gesbert C., Lebel-Binay S., Wiertz E., Ploegh H., Fradelizi D., Conjeaud H. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric β2-microglobulin complexes. J Immunol. 158:1997;2790.
43. Neefjes J.J., Ploegh H.L. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with β2-microglobulin differential effects of inhibition of glycosylation on class I subunit association . Eur J Immunol. 18:1988;801.
44. Khare S.D., Hansen J., Luthra H.S., David C.S. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest. 98:1996;2746.
45. Giacomini P., Beretta A., Nicotra M.R., Ciccarelli G., Martayan A., Cerboni C., Lopalco L., Bini D., Delfino L., Ferrara G.B., Siccardi A.G., Natali P.G. HLA-C heavy chains free of beta2-microglobulin distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsivness . Tissue Antigens. 50:1997;555.
46. Puppo F., Scudeletti M., Indiveri F., Ferrone S. Serum HLA class I antigens markers and modulators of an immune response? Immunol Today. 16:1995;124.
47. Rebmann V., Passler M., Erhard J., Lange R., Eigler F.W., Grosse-Wilde H. Monitoring of soluble HLA class I size variants after liver transplantation. Hum Immunol. 60:1999;424.
48. Bradley J.A. Indirect T cell recognition in allograft rejection. Intern Rev Immunol. 13:1996;245.
49. Ciubotariu R., Liu Z., Colovai A.I., Ho E., Itescu S., Ravalli S., Hardy M.A., Cortesini R., Rose E.A., Suciu-Foca N. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest. 101:1998;398.